Canada Markets closed

Protech Home Medical Corp. (PTQ.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
1.4200-0.0200 (-1.39%)
At close: 3:59PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 5158.82M
Enterprise Value 3137.25M
Trailing P/E 71.00
Forward P/E 123.67
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.72
Price/Book (mrq)3.46
Enterprise Value/Revenue 31.49
Enterprise Value/EBITDA 68.68

Trading Information

Stock Price History

Beta (5Y Monthly) 2.82
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.4800
52 Week Low 30.4700
50-Day Moving Average 31.2042
200-Day Moving Average 31.0146

Share Statistics

Avg Vol (3 month) 3446.1k
Avg Vol (10 day) 3448.89k
Shares Outstanding 5111.84M
Float 106.73M
% Held by Insiders 17.05%
% Held by Institutions 112.79%
Shares Short (Aug. 30, 2020) 437.84k
Short Ratio (Aug. 30, 2020) 40.17
Short % of Float (Aug. 30, 2020) 4N/A
Short % of Shares Outstanding (Aug. 30, 2020) 40.03%
Shares Short (prior month Jul. 30, 2020) 499.22k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Dec. 30, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep. 29, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin 1.84%
Operating Margin (ttm)-1.76%

Management Effectiveness

Return on Assets (ttm)-1.37%
Return on Equity (ttm)3.16%

Income Statement

Revenue (ttm)92.21M
Revenue Per Share (ttm)1.10
Quarterly Revenue Growth (yoy)28.30%
Gross Profit (ttm)57.44M
EBITDA 15.81M
Net Income Avi to Common (ttm)969k
Diluted EPS (ttm)0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.68M
Total Cash Per Share (mrq)0.4
Total Debt (mrq)30.94M
Total Debt/Equity (mrq)67.55
Current Ratio (mrq)2.22
Book Value Per Share (mrq)0.41

Cash Flow Statement

Operating Cash Flow (ttm)32.18M
Levered Free Cash Flow (ttm)28.21M